agreed no conclusion can be made, but if the subanalysis proves to be poor, this stock is going to really hurt because so many are hoping for that to solve the problems from the phase iib top line ann
im just trying to play it safer now that I see a big downside risk to the subanalysis since I got burned by dkd results once already
as I said, I hope they have a strong explanation for the holders but am now skeptical based on their responses on the investor call
good luck everyone!
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-309
-
- There are more pages in this discussion • 319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $217.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 39.0¢ | $370.0K | 934.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25531 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 7985 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |